NHS Digital announces patient de-identification software partnership

NHS Digital announces patient de-identification software partnership

July 5 2018 NHS Digital will introduce new software for the de-identification of patient...

Over half of acute trusts are now using GP e-Referral Service

Over half of acute trusts are now using GP e-Referral Service

June 14 2018 More than 50% of acute hospital trusts in England have switched off paper referrals...

NEWS app for sepsis scoring available

NEWS app for sepsis scoring available

June 4 2018 An app has been re-launched to help clinicians staff across NHS Wales calculate an...

NHS launches National Data Opt-Out facility

NHS launches National Data Opt-Out facility

May 31 2018 NHS patients can formally opt out of having their data used for research or planning...

ePACT to be decommissioned on June 8 as ePACT2 takes over

ePACT to be decommissioned on June 8 as ePACT2 takes over

May 29 2018 NHS Business Services Authority will decommission ePACT with effect from June 8, as...

  • NHS Digital announces patient de-identification software partnership

    NHS Digital announces patient de-identification software partnership

    Thursday, 05 July 2018 16:48
  • Over half of acute trusts are now using GP e-Referral Service

    Over half of acute trusts are now using GP e-Referral Service

    Thursday, 14 June 2018 14:29
  • NEWS app for sepsis scoring available

    NEWS app for sepsis scoring available

    Monday, 04 June 2018 09:58
  • NHS launches National Data Opt-Out facility

    NHS launches National Data Opt-Out facility

    Thursday, 31 May 2018 09:01
  • ePACT to be decommissioned on June 8 as ePACT2 takes over

    ePACT to be decommissioned on June 8 as ePACT2 takes over

    Tuesday, 29 May 2018 12:48

a man taking medication imageFebruary 2 2018

Details of the review into prescribed medicines that may cause dependence or withdrawal have been set out.


Public Health Minister Steve Brine has commissioned Public Health England to review the evidence and report back in early 2019. It has been asked to look at:

  • prevalence and prescribing patterns;
  • the nature and likely causes of dependence or discontinuation syndrome among some people who take these medicines;
  • effective prevention and treatment of dependence and discontinuation syndrome for each drug category.

Drug classes specifically targeted will be benzodiazepines, Z-drugs, GABA-ergic medicines, opioid pain medications, antidepressants, as well as those that are prescribed to treat anxiety, insomnia, chronic non-cancer pain and depression. The review will look at the use of the medicines by adults, and community prescribing.

Not included in the review’s remit are:

  • cancer and terminal pain;
  • over-the-counter medicines;
  • prescribing in hospitals and prisons;
  • other medicines, such as anti-psychotics, stimulants, ‘smart drugs’, or anti-obesity drugs.

PHE will use a number of methods to gather evidence, including “analysing all prescription and some GP patient data to understand prevalence and detail of prescribing patterns, patients and conditions.”

Link:
PHE announcement      

Management News

July 27 2018 Adolescent boys will be offered the human papilloma virus (HPV) vaccine to protect them from cancer, the Department of Health and Social Care has announced.
July 20 2018 Doctors are being reminded to ensure that any patient or other records which may be relevant to the UK Infected Blood Inquiry are not destroyed. Earlier this month, the Inquiry’s Chair, Sir...